To Download a copy of the presentation click here.
To Download a copy of the Q&A Responses here.
*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number NU50CK000574). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.
Moderator:
Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA
Topics and Featured Experts:
Update on the Omicron Variant and Its Subline ages
Deborah Dowell, MD, MPH
CAPT, U.S. Public Health Service
Chief Medical Officer
COVID-19 Response
U.S. Centers for Disease Control and Prevention
Outpatient Treatment Supply & Distribution Update
Meg Sullivan, MD
Acting Chief Medical Officer
Assistant Secretary for Preparedness and Response
Derek Eisner, MD
Medical Officer
Biomedical Advanced Research and Development Authority
COVID-19 Treatment Updates from IDSA’s COVID-19 Rapid Guidelines Panel
Monoclonal Antibody Therapies: What’s In, What’s Out
Lindsey R. Baden, MD
Professor of Medicine, Harvard Medical School
Director of Clinical Research, Division of Infectious Diseases
Brigham and Women’s Hospital
Outpatient COVID-19 Convalescent Plasma Treatment in Immunocompromised Patients
Shmuel Shoham, MD
Professor of Medicine
Division of Infectious Disease
Johns Hopkins University School of Medicine
Emerging Data on Baricite in Hospitalized Patients
Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS
Clinical Professor, Temple University School of Pharmacy
Clinical Specialist, Infectious Diseases
Temple University Hospital
Q&A and Discussion – All Presenters
Mari Nakamura, MD, MPH
Medical Director, Antimicrobial Stewardship
Associate Physician in Pediatrics, Division of Infectious Diseases
Assistant Professor of Pediatrics
Harvard Medical School
